US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exelixis

45.70

+1.052.35%

Volume:1.88M

Turnover:84.58M

Market Cap:12.46B

PE:20.74

High:45.98

Open:44.55

Low:44.21

Close:44.65

Loading ...

Overview Company News Filings

Exelixis Gets Expanded FDA Approval of Cabometyx in Advanced Neuroendocrine Tumors

Here's Why Exelixis (EXEL) is a Strong Growth Stock

BRIEF-Exelixis Announces U.S. FDA Approval Of CABOMETYX® (cabozantinib) For Patients With Previously Treated Advanced Neuroendocrine Tumors

Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors

BRIEF-FDA Approves Cabozantinib For Adults And Pediatric Patients 12 Years Of Age And Older With pNET And epNET

FDA Approves Cabozantinib for Adults and Pediatric Patients 12 Years of Age and Older With Pnet and Epnet

THOMSON REUTERS

Exelixis to Present Positive Preclinical Data Across Its Pipeline Portfolio for Advanced Cancers at AACR 2025

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Exelixis Growth Continues with Big Money Boosts

Exelixis Is Maintained at Outperform by RBC Capital

Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?

Analysts Are Bullish on Top Healthcare Stocks: Werewolf Therapeutics (HOWL), Exelixis (EXEL)

Truist Financial Reaffirms Their Buy Rating on Exelixis (EXEL)

RBC Raises Price Target on Exelixis to $40 From $38, Keeps Outperform Rating

MT Newswires Live

Exelixis Inc : RBC Raises Target Price to $40 From $38

THOMSON REUTERS

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

Top Analyst Reports for Costco, AT&T and Marsh & McLennan

Is Exelixis, Inc. (EXEL) The Best Immunology Stock To Buy Now?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EXEL/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":45.7,"timestamp":1747320781796,"preClose":44.65,"halted":0,"volume":1880125,"delay":0,"floatShares":227734539,"shares":272708280,"eps":2.2037,"marketStatus":"Trading","change":1.05,"latestTime":"05-15 10:53:04 EDT","open":44.548,"high":45.98,"low":44.21,"amount":84576088.23625,"amplitude":0.039642,"askPrice":45.72,"askSize":24,"bidPrice":45.67,"bidSize":432,"shortable":3,"etf":0,"ttmEps":2.2037,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747339200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":44.65,"preHourTrading":{"tag":"盘前","latestPrice":44.35,"preClose":44.65,"latestTime":"09:29 EDT","volume":10074,"amount":447937.91164799995,"timestamp":1747315799999},"postHourTrading":{"tag":"盘后","latestPrice":44.9802,"preClose":44.65,"latestTime":"19:59 EDT","volume":92429,"amount":4127225.8044,"timestamp":1747267148743},"volumeRatio":1.812521,"impliedVol":0.4504,"impliedVolPercentile":0.464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":227734539,"roa":"18.05%","roe":"30.22%","lyrEps":1.797286,"volumeRatio":1.812521,"shares":272708280,"dividePrice":0,"high":45.98,"amplitude":0.039642,"preClose":44.65,"low":44.21,"week52Low":20.14,"pbRate":"5.85","psRate":"5.42","week52High":45.98,"institutionHeld":0.7772,"latestPrice":45.7,"committee":0.894737,"eps":2.2037,"divideRate":0,"volume":1880125,"delay":0,"ttmEps":2.2037,"open":44.548,"prevYearClose":33.3,"prevWeekClose":36.17,"prevMonthClose":39.15,"prevQuarterClose":36.92,"fiveDayClose":36.5,"twentyDayClose":36.15,"sixtyDayClose":35.07},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522804953","title":"Exelixis Gets Expanded FDA Approval of Cabometyx in Advanced Neuroendocrine Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522804953","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522804953?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:46","pubTimestamp":1742996760,"startTime":"0","endTime":"0","summary":"Exelixis has won U.S. Food and Drug Administration expanded  approval of its Cabometyx cancer drug for certain patients with advanced neuroendocrine tumors.Exelixis on Wednesday said the approval covers Cabometyx for patients 12 and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors.The Alameda, Calif., oncology company said the green light makes Cabometyx the first and only systemic treatment that is FDA-approved for previously treated neuroendocrine tumors regardless of primary tumor site, grade, somatostatin receptor expression and functional status.Neuroendocrine tumors are heterogeneous tumors that arise from the neuroendocrine cells of the digestive tract and other organs, such as the lung and pancreas, and most patients with advanced disease face a poor prognosis, Exelixis said.The company's cabozantinib franchise, anchored by Cabometyx, generated $1.81 billion in U.S. net product","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6088","BK4139","EXEL","BK6522","IE0031619046.USD","IE00B19Z4B17.USD","AEIS","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BLZ.SI","BK4157","BK4532"],"gpt_icon":0},{"id":"2522382512","title":"Here's Why Exelixis (EXEL) is a Strong Growth Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522382512","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522382512?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:45","pubTimestamp":1742996708,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.Why This 1 Growth Stock Should Be On Your Watchlist. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time.Seven analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-exelixis-exel-strong-134508754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0},{"id":"2522809990","title":"BRIEF-Exelixis Announces U.S. FDA Approval Of CABOMETYX® (cabozantinib) For Patients With Previously Treated Advanced Neuroendocrine Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522809990","media":"Reuters","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522809990?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:28","pubTimestamp":1742995712,"startTime":"0","endTime":"0","summary":"BRIEF-Exelixis Announces U.S. FDA Approval Of CABOMETYX (cabozantinib) For Patients With Previously Treated Advanced Neuroendocrine TumorsMarch 26 (Reuters) - Exelixis Inc EXEL.O:EXELIXIS ANNOUNCES U.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q915X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","EXEL","BK4139"],"gpt_icon":0},{"id":"2522615804","title":"Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522615804","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522615804?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:15","pubTimestamp":1742994900,"startTime":"0","endTime":"0","summary":"– FDA approval based on the phase 3 CABINET pivotal trial, which demonstrated a statistically significant and clinically meaningful improvement in progression-free survival versus placebo –。– CABOMETYX is now the first and only systemic treatment that is FDA approved for previously treated neuroendocrine tumors regardless of primary tumor site, grade, somatostatin receptor expression and functional status –。– Exelixis is prepared to immediately support these new indications –。ALAMEDA, Calif., March 26, 2025----Exelixis, Inc.  today announced that the U.S. Food and Drug Administration  has approved CABOMETYX  for the treatment of 1) adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic neuroendocrine tumors ; and 2) adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated extra-pancreatic NET . NET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-announces-u-fda-approval-131500269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4585","BK4202","HCC","BK4190","AEIS","BK4613","LU2286300806.USD","BK4116","NET","BK4532","BK4157","BK4006","IE00B7SZL793.SGD","BK4607","BK4560","DTC","RCC","NCI","BK4548","BK4139","IE0031619046.USD","BK4554","BK4588","EXEL"],"gpt_icon":0},{"id":"2522387010","title":"BRIEF-FDA Approves Cabozantinib For Adults And Pediatric Patients 12 Years Of Age And Older With pNET And epNET","url":"https://stock-news.laohu8.com/highlight/detail?id=2522387010","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522387010?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:37","pubTimestamp":1742992644,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Approves Cabozantinib For Adults And Pediatric Patients 12 Years Of Age And Older With pNET And epNETMarch 26  - Exelixis Inc EXEL.O:FDA APPROVES CABOZANTINIB FOR ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER WITH PNET AND EPNETFurther company coverage: EXEL.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90M0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","EXEL","BK4139"],"gpt_icon":0},{"id":"2522044877","title":"FDA Approves Cabozantinib for Adults and Pediatric Patients 12 Years of Age and Older With Pnet and Epnet","url":"https://stock-news.laohu8.com/highlight/detail?id=2522044877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522044877?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:30","pubTimestamp":1742992249,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90M0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXEL","BK4139","BK4532"],"gpt_icon":0},{"id":"2522837366","title":"Exelixis to Present Positive Preclinical Data Across Its Pipeline Portfolio for Advanced Cancers at AACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522837366","media":"Business Wire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522837366?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:15","pubTimestamp":1742937300,"startTime":"0","endTime":"0","summary":"– Presentations will highlight best- and/or first-in-class potential of four small molecule and biotherapeutic development candidates for investigation in patients with advanced solid tumors –。ALAMEDA, Calif., March 25, 2025----Exelixis, Inc.  today announced that preclinical data will be presented for four pipeline molecules at the American Association for Cancer Research  Annual Meeting 2025 taking place April 25-30 in Chicago, IL.Abstract 2936: Preclinical characterization of XB371, a novel anti-tissue factor antibody-drug conjugateLead Author: Kathy Gogas, Ph.D.Session Title: Growth Factor Receptors and Other Surface Antigens as Targets for Therapy 1Monday, April 28, 2:00-5:00 p.m. CTThis poster presentation will highlight preclinical data for XB371, an antibody-drug conjugate, constructed using Catalent’s SMARTag site-specific bioconjugation platform, that pairs a tissue factor-targeting antibody with a topoisomerase inhibitor payload using a novel cleavable linker. This design ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-present-positive-preclinical-data-211500888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z4B17.USD","IE00B66KJ199.SGD","BK4157","IE00B7SZL793.SGD","AEIS","BK4139","EXEL","BK4532","IE0031619046.USD"],"gpt_icon":0},{"id":"2521301237","title":"Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521301237","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521301237?lang=en_us&edition=fundamental","pubTime":"2025-03-21 23:30","pubTimestamp":1742571029,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for Exact Sciences . Shares have lost about 10.6% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Exact Sciences due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.It turns out, estimates revision have trended upward during the past month.The consensus estimate has shifted -20.69% due to these changes.Exact Sciences is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Exelixis , a stock from the same industry, has gained 6%. The company reported its results for the quarter ended December 2024 more than a month ago.Exact Sciences Corporation  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exact-sciences-exas-down-10-153029918.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EXEL","EXAS"],"gpt_icon":0},{"id":"2520631234","title":"Are You a Value Investor? This 1 Stock Could Be the Perfect Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=2520631234","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520631234?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:40","pubTimestamp":1742478010,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.Why Investors Should Pay Attention to This Value Stock. Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks.A company's earnings performance is important for value investors as well. For fiscal 2025, seven analysts revised their earnings estimate higher in the last 60 days for EXEL, while the Zacks Consensus Estimate has increased $0.16 to $2.31 per share. EXEL also holds an average earnings surprise o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/value-investor-1-stock-could-134010834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2520415424","title":"Exelixis Growth Continues with Big Money Boosts","url":"https://stock-news.laohu8.com/highlight/detail?id=2520415424","media":"FX Empire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520415424?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:09","pubTimestamp":1742382594,"startTime":"0","endTime":"0","summary":"EXEL discovers, develops, and commercializes new treatments to battle hard-to-treat cancers. Its product portfolio continues to expand, focusing on more types of tumors, with EXEL treatments proving to be leaders against renal cell carcinoma. The company’s expanding treatment portfolio and ambitious growth plans position it for further expansion.EXEL’s fourth-quarter results for fiscal 2024 showed roughly $567 million in quarterly revenue and almost $140 million in GAAP net income. The company also has almost $2 billion in cash and marketable securities on hand to fund future growth plans, part of which include more share repurchases on top of the almost $656 million bought in 2024. Also, the company is bolstering its oncology pipeline, eyeing revenue of $3 billion for its cabo treatment by 2030 and $5 billion for its zanza treatment by 2033.It’s no wonder EXEL shares are up almost 57% in a year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-growth-continues-big-money-110954953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0},{"id":"2519852250","title":"Exelixis Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2519852250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519852250?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:13","pubTimestamp":1741885980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EXEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2025 13:13 ET (17:13 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"gpt_icon":0},{"id":"2519850428","title":"Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519850428","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519850428?lang=en_us&edition=fundamental","pubTime":"2025-03-13 23:30","pubTimestamp":1741879829,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Exelixis . Shares have added about 13.4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Exelixis due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.It turns out, estimates review have trended upward during the past month.At this time, Exelixis has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.Exelixis belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Amgen , has gained 5.9% over the past month. More than a month has passed since the company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-exel-13-4-since-153029170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMGN","EXEL"],"gpt_icon":0},{"id":"2519831120","title":"Analysts Are Bullish on Top Healthcare Stocks: Werewolf Therapeutics (HOWL), Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519831120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519831120?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:50","pubTimestamp":1741870234,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Werewolf Therapeutics (HOWL – Research Report) and E...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-werewolf-therapeutics-howl-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-werewolf-therapeutics-howl-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","EXEL","HOWL","BK4139","BK4539","BK4137","HCSG"],"gpt_icon":0},{"id":"2519283367","title":"Truist Financial Reaffirms Their Buy Rating on Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519283367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519283367?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:37","pubTimestamp":1741865873,"startTime":"0","endTime":"0","summary":"In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Exelixis (EXEL – Research Report). The company’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-reaffirms-their-buy-rating-on-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-reaffirms-their-buy-rating-on-exelixis-exel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"gpt_icon":0},{"id":"2519838892","title":"RBC Raises Price Target on Exelixis to $40 From $38, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519838892","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519838892?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:28","pubTimestamp":1741865312,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has an average rating of overweight and mean price target of $37.19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL"],"gpt_icon":0},{"id":"2519888475","title":"Exelixis Inc : RBC Raises Target Price to $40 From $38","url":"https://stock-news.laohu8.com/highlight/detail?id=2519888475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519888475?lang=en_us&edition=fundamental","pubTime":"2025-03-13 17:23","pubTimestamp":1741857824,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW0NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EXEL","BK4532"],"gpt_icon":0},{"id":"2517096026","title":"Why This 1 Value Stock Could Be a Great Addition to Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2517096026","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517096026?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:40","pubTimestamp":1741099209,"startTime":"0","endTime":"0","summary":"It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Why Investors Should Pay Attention to This Value Stock. Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks.Alameda, CA-based Exelixis, Inc. is an oncology-focused biotechnology company that primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-1-value-stock-could-144009645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2516622492","title":"Exploring 3 High Growth Tech Stocks In The US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2516622492","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516622492?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:08","pubTimestamp":1741086498,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 13% over the past year with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves examining companies that demonstrate strong potential for expansion and innovation amidst these dynamic market conditions.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 234 stocks from our US High Growth Tech and AI Stocks screener.Operations: TG Therapeutics focuses on developing and commercializing novel treatments for B-cell mediated diseases both in the U.S. and internationally. The company operates as a commercial stage biopharmaceutical entity, leveraging its expertise in acquiring innovative therapies to address unmet medical needs.NasdaqCM:TGTX Earnings and Revenue Growth as at Mar 2025. Overview: Exelixis, Inc. is an oncology company dedicated to discovering, developing, and commercializing new medicines f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-3-high-growth-tech-110818308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WAY","TGTX","EXEL","BK4167"],"gpt_icon":0},{"id":"2516660376","title":"Top Analyst Reports for Costco, AT&T and Marsh & McLennan","url":"https://stock-news.laohu8.com/highlight/detail?id=2516660376","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516660376?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:50","pubTimestamp":1741038600,"startTime":"0","endTime":"0","summary":"Monday, March 3, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-analyst-reports-costco-t-215000918.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","IE00BSNM7G36.USD","T","LPLA","STE","BK4604","LU1496350502.SGD","LU2095319765.USD","COST","LU0205193047.USD","LU0234572021.USD","MMC","LU0385154629.USD","ACHC","EME","APTV","IE00BMPRXN33.USD","LU0477156797.USD","LU2098885051.SGD","LU1548497426.USD","MHK","BK4127","LU1721428933.USD","LU2237438978.USD","EIX","LU2087625088.SGD","BK4534","LU1861215975.USD","AIRT","DK","LU1093756325.SGD","BK4177","LU1571399168.USD","LU0006061336.USD","LU2449327464.USD","KDP","LU1861220033.SGD","IE00BMG7P694.USD","PPL","EXEL","IE00BJTD4N35.SGD","LU2272731782.SGD","BK4550","LU1363072403.SGD","GM","BK4581","LU1035775433.USD","AIRTP","LU0079474960.USD","LU0130102774.USD"],"gpt_icon":1},{"id":"2516134565","title":"Is Exelixis, Inc. (EXEL) The Best Immunology Stock To Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516134565","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516134565?lang=en_us&edition=fundamental","pubTime":"2025-03-02 03:38","pubTimestamp":1740857884,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where Exelixis, Inc.  stands against other best immunology stocks to buy now.Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies. As the global demand for innovative treatments for autoimmune diseases, cancer immunotherapies, and vaccines continues to rise, immunology stocks present lucrative investment opportunities. The market for immunotherapy medications is expected to rise at a high pace, from $240 billion in 2023 to $1.3 trillion in 2033. The rise in chronic illnesses like infections, autoimmune diseases, and various forms of cancer worldwide is what is causing the surge.In 2024, there will likely be more than 2 million new instances of cancer in the US, which will increase demand for efficient therapies like immunotherapy. To provide patients with incurable malignancies lik","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exelixis-inc-exel-best-immunology-193804546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","TQQQ","NQmain","USJW.SI","QID",".IXIC","SQQQ","TSYW.SI","USAW.SI","PSQ","EXEL","NVIW.SI","QLD","BK4532","MNQmain"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"EXEL","fiscalQuarterEnding":"2025/03","expectedEps":0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":0.53},{"market":"US","date":"2025-02-11","symbol":"EXEL","fiscalQuarterEnding":"2024/12","expectedEps":0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2025-01-12","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736658000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-10-29","symbol":"EXEL","fiscalQuarterEnding":"2024/09","expectedEps":0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"post","actualEps":0.4},{"market":"US","date":"2024-08-06","symbol":"EXEL","fiscalQuarterEnding":"2024/06","expectedEps":0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.35,"hold":0.45,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.35,"analysts":20,"updateTime":1740456000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2025-05-14","current":15.657401,"percent":0,"low":15.657401,"twenty":21.145983,"median":31.337682,"eighty":58.191612,"high":123.671097,"avg":38.257614,"sd":22.172705,"marketCap":10076570946},"quantilePoints":[{"date":"2020-05-15","current":26.882959,"twenty":-27.325861,"median":-2.655085,"eighty":16.477819,"marketCap":7899530533},{"date":"2020-05-22","current":25.693263,"twenty":-27.325861,"median":-2.655085,"eighty":16.669769,"marketCap":7549939508},{"date":"2020-05-29","current":25.787186,"twenty":-27.325861,"median":-2.655085,"eighty":16.772736,"marketCap":7577538799},{"date":"2020-06-05","current":23.345178,"twenty":-27.325861,"median":-2.655085,"eighty":16.914711,"marketCap":6859957221},{"date":"2020-06-12","current":23.36605,"twenty":-27.325861,"median":-2.655085,"eighty":17.072198,"marketCap":6866090397},{"date":"2020-06-19","current":25.234082,"twenty":-27.325861,"median":-2.655085,"eighty":17.193665,"marketCap":7415009638},{"date":"2020-06-26","current":23.877411,"twenty":-27.325861,"median":-2.498063,"eighty":17.327033,"marketCap":7016353206},{"date":"2020-07-02","current":24.503566,"twenty":-27.325861,"median":2.570279,"eighty":17.449214,"marketCap":7200348483},{"date":"2020-07-10","current":26.027212,"twenty":-27.325861,"median":7.700066,"eighty":17.686188,"marketCap":7648070322},{"date":"2020-07-17","current":25.672391,"twenty":-27.325861,"median":7.798866,"eighty":17.752451,"marketCap":7543806332},{"date":"2020-07-24","current":25.661955,"twenty":-27.325861,"median":7.918086,"eighty":17.906096,"marketCap":7540739744},{"date":"2020-07-31","current":24.096565,"twenty":-27.325861,"median":7.952297,"eighty":18.137028,"marketCap":7080751553},{"date":"2020-08-07","current":24.532882,"twenty":-27.325861,"median":8.048191,"eighty":18.372123,"marketCap":6909146512},{"date":"2020-08-14","current":24.115955,"twenty":-27.325861,"median":8.142361,"eighty":18.523046,"marketCap":6791728101},{"date":"2020-08-21","current":24.412193,"twenty":-27.325861,"median":8.236764,"eighty":18.814893,"marketCap":6875156972},{"date":"2020-08-28","current":23.731943,"twenty":-27.325861,"median":8.306231,"eighty":18.921262,"marketCap":6683579564},{"date":"2020-09-04","current":22.678653,"twenty":-27.325861,"median":8.452997,"eighty":19.15433,"marketCap":6386943578},{"date":"2020-09-11","current":23.84166,"twenty":-27.325861,"median":8.522074,"eighty":19.393808,"marketCap":6714479146},{"date":"2020-09-18","current":29.404349,"twenty":-27.325861,"median":8.639223,"eighty":21.878582,"marketCap":8281087949},{"date":"2020-09-25","current":26.156704,"twenty":-27.325861,"median":8.733376,"eighty":22.567702,"marketCap":7366460324},{"date":"2020-10-02","current":25.673946,"twenty":-27.325861,"median":8.760246,"eighty":22.741605,"marketCap":7230502164},{"date":"2020-10-09","current":26.233507,"twenty":-27.325861,"median":8.79746,"eighty":22.926619,"marketCap":7388090032},{"date":"2020-10-16","current":25.487426,"twenty":-27.325861,"median":8.876649,"eighty":23.321013,"marketCap":7177972875},{"date":"2020-10-23","current":24.45608,"twenty":-27.325861,"median":8.972487,"eighty":23.456447,"marketCap":6887516805},{"date":"2020-10-30","current":22.470189,"twenty":-27.325861,"median":8.98742,"eighty":23.487127,"marketCap":6328234373},{"date":"2020-11-06","current":42.232952,"twenty":-27.325861,"median":9.087264,"eighty":23.557982,"marketCap":6425152432},{"date":"2020-11-13","current":41.111363,"twenty":-27.325861,"median":9.098481,"eighty":23.685842,"marketCap":6254518253},{"date":"2020-11-20","current":38.562295,"twenty":-27.325861,"median":9.113834,"eighty":23.779449,"marketCap":5866713302},{"date":"2020-11-27","current":39.581922,"twenty":-27.325861,"median":9.129175,"eighty":23.84411,"marketCap":6021835283},{"date":"2020-12-04","current":38.705043,"twenty":-27.325861,"median":9.164612,"eighty":23.920269,"marketCap":5888430379},{"date":"2020-12-11","current":40.519979,"twenty":-27.325861,"median":9.190147,"eighty":24.042286,"marketCap":6164547505},{"date":"2020-12-18","current":40.683119,"twenty":-27.325861,"median":9.209534,"eighty":24.112523,"marketCap":6189367021},{"date":"2020-12-24","current":42.232952,"twenty":-27.325861,"median":9.239511,"eighty":24.160872,"marketCap":6425152432},{"date":"2020-12-31","current":40.92783,"twenty":-27.325861,"median":9.247119,"eighty":24.259288,"marketCap":6226596297},{"date":"2021-01-08","current":46.535778,"twenty":-27.325861,"median":9.290936,"eighty":24.393046,"marketCap":7079767190},{"date":"2021-01-15","current":48.381303,"twenty":-27.325861,"median":9.331472,"eighty":24.439962,"marketCap":7360537974},{"date":"2021-01-22","current":45.149086,"twenty":-27.325861,"median":9.352389,"eighty":24.47852,"marketCap":6868801296},{"date":"2021-01-29","current":45.291833,"twenty":-27.325861,"median":9.385679,"eighty":24.575729,"marketCap":6890518373},{"date":"2021-02-05","current":47.249517,"twenty":-27.325861,"median":9.422035,"eighty":24.692782,"marketCap":7188352576},{"date":"2021-02-12","current":61.152553,"twenty":-27.325861,"median":9.475859,"eighty":24.765611,"marketCap":6835693472},{"date":"2021-02-19","current":61.989876,"twenty":-27.325861,"median":9.52696,"eighty":24.818203,"marketCap":6929290370},{"date":"2021-02-26","current":60.454783,"twenty":-27.325861,"median":9.582451,"eighty":24.859848,"marketCap":6757696057},{"date":"2021-03-05","current":62.324806,"twenty":-27.329077,"median":9.628878,"eighty":24.949115,"marketCap":6966729130},{"date":"2021-03-12","current":64.976331,"twenty":-27.329077,"median":9.656734,"eighty":25.006772,"marketCap":7263119308},{"date":"2021-03-19","current":65.311261,"twenty":-27.329077,"median":9.710451,"eighty":25.161223,"marketCap":7300558067},{"date":"2021-03-26","current":63.329595,"twenty":-27.325861,"median":9.736947,"eighty":25.234082,"marketCap":7079045408},{"date":"2021-04-01","current":64.529759,"twenty":-27.325861,"median":9.747742,"eighty":25.270502,"marketCap":7213200962},{"date":"2021-04-09","current":64.529759,"twenty":-27.329077,"median":9.805299,"eighty":25.357929,"marketCap":7213200962},{"date":"2021-04-16","current":66.075436,"twenty":-27.329077,"median":9.834498,"eighty":25.412148,"marketCap":7385978281},{"date":"2021-04-23","current":69.268568,"twenty":-27.329077,"median":9.92067,"eighty":25.491815,"marketCap":7742909830},{"date":"2021-04-30","current":68.960459,"twenty":-27.329077,"median":9.944579,"eighty":25.677015,"marketCap":7708469067},{"date":"2021-05-07","current":121.493789,"twenty":-27.329077,"median":9.977077,"eighty":25.790166,"marketCap":7869152717},{"date":"2021-05-14","current":123.671097,"twenty":-27.329077,"median":10.042797,"eighty":25.900353,"marketCap":8010176959},{"date":"2021-05-21","current":118.348789,"twenty":-27.329077,"median":10.090291,"eighty":26.029567,"marketCap":7665451034},{"date":"2021-05-28","current":109.107325,"twenty":-27.329077,"median":10.142137,"eighty":26.116578,"marketCap":7066881472},{"date":"2021-06-04","current":108.236402,"twenty":-27.329077,"median":10.259913,"eighty":26.305665,"marketCap":7010471775},{"date":"2021-06-11","current":111.187864,"twenty":-27.329077,"median":10.30588,"eighty":26.528137,"marketCap":7201637970},{"date":"2021-06-18","current":108.429941,"twenty":-27.329077,"median":10.499122,"eighty":26.899667,"marketCap":7023007264},{"date":"2021-06-25","current":113.316788,"twenty":-27.329077,"median":10.577409,"eighty":27.427848,"marketCap":7339528341},{"date":"2021-07-02","current":88.350322,"twenty":-27.329077,"median":10.668743,"eighty":28.437015,"marketCap":5722450363},{"date":"2021-07-09","current":87.140707,"twenty":-27.329077,"median":10.768777,"eighty":32.735526,"marketCap":5644103562},{"date":"2021-07-16","current":81.286167,"twenty":-27.329077,"median":12.586346,"eighty":38.333898,"marketCap":5264905044},{"date":"2021-07-23","current":80.947475,"twenty":-27.329077,"median":13.259462,"eighty":38.843712,"marketCap":5242967939},{"date":"2021-07-30","current":81.52809,"twenty":-27.329077,"median":13.665176,"eighty":39.250255,"marketCap":5280574404},{"date":"2021-08-06","current":57.789598,"twenty":-27.329077,"median":14.041856,"eighty":39.491398,"marketCap":5434591593},{"date":"2021-08-13","current":61.240223,"twenty":-27.329077,"median":14.246084,"eighty":40.05544,"marketCap":5759091844},{"date":"2021-08-20","current":61.776243,"twenty":-27.329077,"median":14.431907,"eighty":40.44398,"marketCap":5809499650},{"date":"2021-08-27","current":65.092863,"twenty":-27.329077,"median":14.633356,"eighty":40.76874,"marketCap":6121397950},{"date":"2021-09-03","current":66.231905,"twenty":-27.329077,"median":14.930088,"eighty":41.024831,"marketCap":6228514538},{"date":"2021-09-10","current":66.868428,"twenty":-27.329077,"median":15.002715,"eighty":41.184268,"marketCap":6288373808},{"date":"2021-09-17","current":69.41452,"twenty":-27.329077,"median":15.270884,"eighty":41.645802,"marketCap":6527810887},{"date":"2021-09-24","current":68.174975,"twenty":-27.329077,"median":15.454005,"eighty":42.220717,"marketCap":6411242835},{"date":"2021-10-01","current":72.16162,"twenty":-27.329077,"median":15.627908,"eighty":42.663031,"marketCap":6786150893},{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":29.519358,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6053062389},{"date":"2024-06-07","current":31.50815,"twenty":17.668364,"median":30.926871,"eighty":50.389968,"marketCap":6460872174},{"date":"2024-06-14","current":31.195625,"twenty":17.731278,"median":31.024392,"eighty":50.736642,"marketCap":6396787779},{"date":"2024-06-21","current":30.868895,"twenty":17.766317,"median":31.025137,"eighty":51.083315,"marketCap":6329790457},{"date":"2024-06-28","current":32.005348,"twenty":17.852912,"median":31.063965,"eighty":53.63882,"marketCap":6562824621},{"date":"2024-07-05","current":31.195625,"twenty":17.982935,"median":31.110391,"eighty":53.63882,"marketCap":6396787779},{"date":"2024-07-12","current":32.033759,"twenty":18.146511,"median":31.178387,"eighty":53.63882,"marketCap":6568650475},{"date":"2024-07-15","current":31.820674,"twenty":18.176822,"median":31.195625,"eighty":53.63882,"marketCap":6524956569},{"date":"2024-08-02","current":34.406104,"twenty":18.456098,"median":31.288944,"eighty":57.789598,"marketCap":7055109290},{"date":"2024-08-09","current":22.14419,"twenty":18.510802,"median":31.323476,"eighty":57.789598,"marketCap":7750289368},{"date":"2024-08-16","current":21.44327,"twenty":18.768662,"median":31.323476,"eighty":57.789598,"marketCap":7504972884},{"date":"2024-08-23","current":21.011307,"twenty":18.973137,"median":31.323476,"eighty":57.789598,"marketCap":7353789470},{"date":"2024-08-30","current":21.206913,"twenty":19.112302,"median":31.323476,"eighty":57.789598,"marketCap":7422249884},{"date":"2024-09-06","current":20.840152,"twenty":19.183708,"median":31.323476,"eighty":57.789598,"marketCap":7293886608},{"date":"2024-09-13","current":21.44327,"twenty":19.289956,"median":31.323476,"eighty":57.789598,"marketCap":7504972884},{"date":"2024-09-20","current":21.867082,"twenty":19.478842,"median":31.323476,"eighty":57.789598,"marketCap":7653303781},{"date":"2024-09-27","current":21.386218,"twenty":19.575801,"median":31.323476,"eighty":57.789598,"marketCap":7485005264},{"date":"2024-10-04","current":21.386218,"twenty":19.877132,"median":31.323476,"eighty":57.789598,"marketCap":7485005264},{"date":"2024-10-11","current":20.954256,"twenty":20.21075,"median":31.323476,"eighty":57.789598,"marketCap":7333821849},{"date":"2024-10-18","current":23.684585,"twenty":20.318368,"median":31.323476,"eighty":57.789598,"marketCap":8289415128},{"date":"2024-10-25","current":22.910312,"twenty":20.693448,"median":31.323476,"eighty":57.789598,"marketCap":8018425989},{"date":"2024-10-31","current":19.840881,"twenty":20.791251,"median":31.323476,"eighty":57.789598,"marketCap":9264183408},{"date":"2024-11-08","current":21.895917,"twenty":20.951195,"median":31.330579,"eighty":57.923603,"marketCap":10223728916},{"date":"2024-11-15","current":21.437203,"twenty":20.974348,"median":31.330579,"eighty":57.923603,"marketCap":10009544651},{"date":"2024-11-22","current":21.302647,"twenty":21.045396,"median":31.330579,"eighty":57.923603,"marketCap":9946717266},{"date":"2024-11-29","current":22.299584,"twenty":21.095503,"median":31.330579,"eighty":57.923603,"marketCap":10412211069},{"date":"2024-12-06","current":22.042705,"twenty":21.156382,"median":31.330579,"eighty":57.923603,"marketCap":10292267880},{"date":"2024-12-13","current":21.516713,"twenty":21.234624,"median":31.330579,"eighty":57.923603,"marketCap":10046669923},{"date":"2024-12-20","current":20.599287,"twenty":21.262689,"median":31.330579,"eighty":57.923603,"marketCap":9618301393},{"date":"2024-12-27","current":20.813353,"twenty":21.262689,"median":31.330579,"eighty":57.923603,"marketCap":9718254050},{"date":"2025-01-03","current":20.758307,"twenty":21.262689,"median":31.330579,"eighty":57.923603,"marketCap":9692551938},{"date":"2025-01-10","current":21.100813,"twenty":21.272083,"median":31.337682,"eighty":58.057608,"marketCap":9852476190},{"date":"2025-01-17","current":22.35463,"twenty":21.382958,"median":31.337682,"eighty":58.057608,"marketCap":10437913181},{"date":"2025-01-24","current":20.874515,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9746811952},{"date":"2025-01-31","current":20.140573,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9404117128},{"date":"2025-02-07","current":20.593171,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9615445603},{"date":"2025-02-14","current":18.518554,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9653111210},{"date":"2025-02-21","current":18.840709,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9821040080},{"date":"2025-02-28","current":20.215238,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":10537536592},{"date":"2025-03-07","current":20.515916,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10694270204},{"date":"2025-03-14","current":19.758852,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10299637360},{"date":"2025-03-21","current":19.962883,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10405992311},{"date":"2025-03-28","current":19.780329,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10310832618},{"date":"2025-04-04","current":19.694421,"twenty":21.399258,"median":31.337682,"eighty":58.191612,"marketCap":10266051586},{"date":"2025-04-11","current":18.502446,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":9644714767},{"date":"2025-04-17","current":19.40985,"twenty":21.386218,"median":31.337682,"eighty":58.057608,"marketCap":10117714417},{"date":"2025-04-25","current":19.978991,"twenty":21.325677,"median":31.337682,"eighty":58.191612,"marketCap":10414388754},{"date":"2025-05-02","current":20.560404,"twenty":21.243567,"median":31.337682,"eighty":58.191612,"marketCap":10717460009},{"date":"2025-05-09","current":19.296856,"twenty":21.198299,"median":31.337682,"eighty":58.191612,"marketCap":10058814357},{"date":"2025-05-14","current":15.657401,"twenty":21.145983,"median":31.337682,"eighty":58.191612,"marketCap":10076570946}],"updateTime":1747306828508}}}